Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
various product lines
|
| gptkbp:aimsTo |
improve patient outcomes
|
| gptkbp:collaboratesWith |
academic institutions
|
| gptkbp:employs |
researchers
scientists pharmaceutical professionals |
| gptkbp:engagesIn |
clinical trials
|
| gptkbp:focusesOn |
specialty pharmaceuticals
|
| gptkbp:founded |
2014
|
| gptkbp:hasFilm |
transform healthcare
enhance treatment options support healthcare professionals |
| gptkbp:hasMission |
advance healthcare
|
| gptkbp:hasPartnershipsWith |
research organizations
other pharmaceutical companies biotech_firms |
| gptkbp:hasProductLine |
neurology
oncology autoimmune diseases infectious diseases |
| gptkbp:hasResearchFocus |
patient safety
drug development therapeutic efficacy |
| gptkbp:hasResidence |
multiple products
|
| gptkbp:headquarters |
gptkb:New_Jersey
|
| https://www.w3.org/2000/01/rdf-schema#label |
Renaissance Pharma
|
| gptkbp:isActiveIn |
gptkb:Asia
gptkb:North_America Europe |
| gptkbp:isDedicatedTo |
innovation
sustainability corporate responsibility |
| gptkbp:isInvolvedIn |
community outreach
patient advocacy health education |
| gptkbp:isKnownFor |
innovative therapies
|
| gptkbp:isLedBy |
experienced executives
|
| gptkbp:isRecognizedFor |
quality standards
ethical practices |
| gptkbp:isSupportedBy |
investors
|
| gptkbp:offers |
generic medications
|
| gptkbp:participatesIn |
healthcare_conferences
|
| gptkbp:partnerships |
healthcare_providers
|
| gptkbp:utilizes |
biotechnology
data analytics clinical research |